Scholtz & Company, LLC Editas Medicine, Inc. Transaction History

Scholtz & Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $161,203 - $299,418	-4,105 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$31.29 - $56.64 $128,445 - $232,507	4,105 New	4,105 $233,000
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $236,473 - $539,403	-5,955 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $161,201 - $502,304	5,955 New	5,955 $418,000

247

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $168M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Scholtz & Company, LLC with notifications on news.